Intafer 100mg Injection

Introduction

Intafer is a medication that contains Ferrous Ascorbate as its active ingredient. It is commonly available in the form of an injection and is used for various medical purposes.

Uses

Intafer is primarily prescribed to treat iron deficiency anemia and to replenish iron stores in the body. Iron deficiency anemia occurs when the body lacks sufficient iron to produce healthy red blood cells, which can lead to symptoms such as fatigue, weakness, and shortness of breath.

Dosage and Administration

The dosage of Intafer may vary depending on the individual’s specific needs and the severity of the iron deficiency. It is usually administered by a healthcare professional through intravenous (IV) infusion or intramuscular (IM) injection. The exact dosage and administration method will be determined by your healthcare provider.

Mechanism of Action

Ferrous Ascorbate, the active ingredient in Intafer, works by increasing the levels of iron in the body. Iron is an essential mineral that is necessary for the production of hemoglobin, a protein responsible for carrying oxygen in the blood. By replenishing iron stores, Intafer helps improve the production of red blood cells, thereby alleviating symptoms of iron deficiency anemia.

Side Effects

Common side effects may include nausea, vomiting, constipation, diarrhea, stomach cramps, and dark stools. These side effects are usually mild and temporary.

In rare cases, serious side effects such as severe allergic reactions, difficulty breathing, chest pain, rapid heartbeat, or swelling of the face, lips, or tongue may occur. If you experience any of these serious side effects, seek immediate medical attention.

Drug Interactions

inform your healthcare provider about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. Some medications may interact with Intafer, potentially affecting its effectiveness or increasing the risk of side effects. Discuss any potential drug interactions with your healthcare provider before starting Intafer.

Precautions

Before using Intafer, inform your healthcare provider if you have any known allergies, especially to iron or any other ingredients in the medication. Additionally, let your healthcare provider know about any existing medical conditions or if you are pregnant, planning to become pregnant, or breastfeeding.

Intafer should be used with caution in individuals with certain conditions, such as liver disease or kidney disease. Follow your healthcare provider’s instructions and dosage recommendations for safe and effective use of the medication.

Storage

Intafer should be stored at room temperature, away from direct sunlight and moisture. Keep it out of the reach of children and pets. Do not use the medication if it has expired or if the packaging is damaged. Proper storage helps maintain the quality and effectiveness of the medication.

Patient Tips

• Follow your healthcare provider’s instructions regarding the dosage and administration of the medication.
• If you miss a dose, contact your healthcare provider for further guidance. Do not double the dose to make up for a missed one.
• Maintain a well-balanced diet that includes foods rich in iron, such as lean meats, beans, leafy green vegetables, and fortified cereals, to support the effectiveness of Intafer.
• If you experience any unusual or persistent symptoms while using Intafer, consult your healthcare provider for further evaluation.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Total iron-binding capacity (TIBC) and transferrin test (NHS UK) [Accessed 25 Jun. 2024] (online) Available at:
• CosmoFer (Health Professionals SmPC) Available at:
• Carbonyl iron (Drugs.com) [Accessed 24 Jun. 2024] (online) Available at:
• carbonyl iron pediatric suspension (OTC) [Accessed 2 Jun. 2024] (online) Available at:
• Basic Information about Mercury (Environmental Protection Agency) [Accessed 29 Jun. 2024] (online) Available at:
• Xiao Z, Zhong W, Liu X. Recent developments in electrochemical investigations into iron carbonyl complexes relevant to the iron centres of hydrogenases. Dalton Trans. 2021 Dec 20;51(1):40-47. doi: 10.1039/d1dt02705k. [Accessed 22 Jun. 2024] Available at: